Definitive Healthcare Corp.

NASDAQ:DH

Medical - Healthcare Information Services

Healthcare
$1.34 +1.85%

+$0.01 today

Market cap
$143.60M
Beta
1.33
P/E (TTM)
-0.5
EPS (TTM)
-$1.63
52W Low $0.77High $4.70

Volume 0.43M

Average 0.32M

DH EBITDA Margin

EBITDA as a percentage of revenue.

Definitive Healthcare Corp.NASDAQ: DH

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 15.0%

EBITDA Margin was 15.0% in Q1 FY2026, up 268.0 pp from a year earlier. On a trailing-twelve-month basis it was 4.9%, up 295.3 pp year over year. Over 3 fiscal years it narrowed by 78.9 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 40.1% for the fiscal year ending Dec 2026, up from -67.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
15.0%+23.4 pp QoQ
Last fiscal yearDec 2025
-67.1%+157.8 pp YoY
LTMMar 2026
4.9%+295.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+268.0 pp+26.0 pp-242.0 pp
1 year+157.8 pp+107.2 pp-50.6 pp
3 years-78.9 pp+100.8 pp+179.7 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-67.1%
Year-over-year change
+157.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How DH compares with its peers on the latest reported figures

  • DH's LTM Mar 2026 EBITDA Margin of 4.9% is the 5th highest of the 8 companies compared; the peer median is 9.4%.
  • Its year-over-year change of +295.3 pp is the 2nd highest of 8, against a peer median of -3.3 pp.
  • Over three fiscal years its change of -78.9 pp compares with a peer median of -2.4 pp.
DH Competitors Peer median
EBITDA Margin for DH and competitors
Company Period LTM level YoY 3-year change
SLPSimulations Plus, Inc.LTM Feb 202621.5% +0.4 pp-16.1 pp
NRCNational Research CorporationLTM Mar 202620.1% -9.1 pp-10.5 pp
SPOKSpok Holdings, Inc.LTM Mar 202616.3% -1.8 pp+14.4 pp
TBRGTruBridge, Inc.LTM Mar 20269.4% -3.3 pp-2.4 pp
DHDefinitive Healthcare Corp.LTM Mar 20264.9% +295.3 pp-78.9 pp
SOPHSOPHiA GENETICS S.A.LTM Mar 2026-81.4% -6.3 pp+87.8 pp
EDITEditas Medicine, Inc.LTM Mar 2026-258.7% +387.8 pp+719.4 pp
NAKANakamoto Inc.LTM Mar 2026-7060.9% -6900.9 pp-2402.8 pp
KYTXKyverna Therapeutics, Inc.FY2025— ——
CABACabaletta Bio, Inc.FY2025— ——
Peer median (excluding DH) 9.4%-3.3 pp-2.4 pp

Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue166.15M222.65M251.42M252.2M241.52M
Cost of Revenue40.69M42.63M47.48M54.73M58.25M
Gross Profit125.47M180.03M203.93M197.47M183.28M
Gross Margin75.5%80.9%81.1%78.3%75.9%
Research & Development18.57M34.89M42.44M36.52M34.78M
Selling, General & Admin89.25M141.15M153.4M133.07M133.26M
Operating Expenses152.78M224.07M533.73M908.29M203.86M
Depreciation & Amortization59.95M56.9M51.75M51.67M35.82M
EBITDA23.08M26.23M(241.23M)(567.24M)(162.15M)
EBITDA Margin13.9%11.8%-95.9%-224.9%-67.1%
Operating Income(27.32M)(44.04M)(329.8M)(710.82M)(20.58M)
Operating Margin-16.4%-19.8%-131.2%-281.8%-8.5%
Interest Income29K2.79M13.64M14.59M6.95M
Interest Expense25.9M11.2M15.2M14.84M11.29M
Other Income / Expenses(35.45M)2.17M21.62M77.08M(188.67M)
Income Before Tax(62.77M)(41.88M)(308.18M)(633.75M)(209.26M)
Pre-Tax Margin-37.8%-18.8%-122.6%-251.3%-86.6%
Income Tax Expense(443K)(17.7M)(18.55M)(42.3M)(9.96M)
Net Income(51.91M)(7.22M)(202.39M)(413.12M)(138.93M)
Net Margin-31.2%-3.2%-80.5%-163.8%-57.5%
EPS (Basic)(0.19)(0.07)(1.79)(3.54)(1.30)
EPS (Diluted)(0.19)(0.07)(1.79)(3.54)(1.30)
Weighted Avg Shares97.03M101.11M112.76M116.64M106.65M
Weighted Avg Shares (Diluted)97.03M101.11M112.76M116.64M106.65M

Definitive Healthcare Corp.

NASDAQ:DH

Intrinsic Alpha fair value

Locked

Current Price

$1.34

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.